XML 34 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
14. Stock-Based Compensation
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
14. Stock-Based Compensation

We have various incentive stock-based compensation plans that provide for the grant of stock options, restricted stock, and other share-based awards of up to 5,898,729 shares to eligible employees, consultants, and directors. As of December 31, 2015, we had 1,268,031 shares remaining in the plans available to grant.

 

The following table summarizes the statement of operations effect of stock-based compensation for the years ended December 31, 2015 and 2014 (in thousands):

 

    Year Ended December 31,  
    2015     2014  
Share based compensation expense by financial statement line item:            
Cost of revenue   $ 80     $ 25  
Research and development     166       129  
Selling and marketing     115       64  
General and administrative     945       566  
Total cost related to share-based compensation expense   $ 1,306     $ 784  

 

Total cost allocated to share-based compensation expense related to warrants issued during the year ended December 31, 2015 and 2014 was $0 and $265,000, respectively (Note 13).

 

There is no tax benefit related to stock compensation expense due to a full valuation allowance on net deferred tax assets at December 31, 2015 and 2014, respectively.

  

Stock Options

 

The weighted-average fair value of stock options on the date of grant and the assumptions used to estimate the fair value of stock options granted during the years ended December 31, 2015 and 2014 using the Black-Scholes option-pricing model were as follows:

 

 

 

    Year Ended December 31, 2015     Year Ended December 31, 2014  
Weighted-average fair value of options and warrants granted   $ 0.69     $ 1.01  
Expected volatility     58 %     55 %
Expected life (in years)     4.30       4.60  
Risk-free interest rate     1.68 %     1.65 %
Expected dividend yield     0.00 %     0.00 %

 

The expected volatility of the options is determined using historical volatilities based on historical stock prices. The expected life of the options granted is based on our historical share option exercise experience. The risk-free interest rate is determined using the yield available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the option. The Company has not declared any dividends, therefore, it is assumed to be zero.

 

The following table summarizes the stock option activity for all plans for the years ended December 31, 2015 and 2014:

 

            Weighted-Average Aggregate
    Weighted-Average   Remaining Intrinsic Value
  Number of Shares   Exercise Price   Contract Life (in thousands)
Outstanding at January 1, 2014   2,130,239   $ 3.96   8.0 years  $            482
Granted       498,000                                3.18      
Exercised         (28,418)                               2.44      
Cancelled/forfeited     (452,260)                               4.05      
Outstanding at December 31, 2014    2,147,561                               3.78   6.9 years                      -
Granted  2,578,000                                1.50      
Exercised        (26,865)                                1.85      
Cancelled/forfeited      (317,998)                                2.16      
Outstanding at December 31, 2015  4,380,698                               2.56   6.2 years                      -
Shares vested and expected to vest   4,052,341                               2.56   6.2 years                      -
Exercisable as of December 31, 2015   2,716,262                               3.04   6.1 years                      -
Exercisable as of December 31, 2014    1,351,894                                4.18   6.6 years                      -

 

The total intrinsic value of options exercised during the years ended December 31, 2015 and 2014, was $8,000 and $21,000 respectively.

 

As of December 31, 2015, the total future compensation expense related to non-vested options not yet recognized in the consolidated statements of operations was approximately $1,325,000 and the weighted-average period over which these awards are expected to be recognized is approximately 2.0 years.